Inside Valeant's Bid to Be a Normal Drug Company

Valeant Pharmaceuticals, which has been Exhibit A of corporate turbulence since 2015, is trying to get back to being a normal drug company. But it faces a steep climb to good health.

from WSJ.com: US Business http://ift.tt/2zL77XT
via IFTTT